Biodesix, Inc. (BDSX)

NASDAQ: BDSX · Real-Time Price · USD

18.72

-0.68 (-3.51%)

At close: Mar 10, 2026, 4:00 PM EDT

19.69

+0.97 (5.18%)

After-hours: Mar 10, 2026, 7:12 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Providing Diagnostic Testing Services	88.50M	71.32M	49.09M	38.21M	54.51M
Providing Diagnostic Testing Services Growth	24.08%	45.30%	28.46%	-29.89%	19.64%
Total	88.50M	71.32M	49.09M	38.21M	54.51M
Total Growth	24.08%	45.30%	28.46%	-29.89%	19.64%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States	88.50M	71.32M	49.09M	38.21M	54.51M
United States Growth	24.08%	45.30%	28.46%	-29.89%	19.64%
Total	88.50M	71.32M	49.09M	38.21M	54.51M
Total Growth	24.08%	45.30%	28.46%	-29.89%	19.64%

Source: S&P Global Market Intelligence.